Board of Directors

Next Board of Directors meeting: Wednesday,  November 20, 2019 at 5 p.m. at the PCSANM office

 

Steve Denning

Steve Denning

Chairman of the Board

Steve was first diagnosed in 2009 and treated with brachytherapy and cryotherapy the next year.  His PSA continues to stay low.  He joined the board of PCSANM in 2014 and wishes he had known about the organization at the time of his treatment.  Steve is now retired but worked most of his life as a video producer in advertising and manufacturing.  Steve has been a private business owner but his last 17 years working were at Intel.  He is happy to share the knowledge and experience he gained in his role on the board and as a volunteer.
Rod Geer

Rod Geer

Vice Chair

Rod joined the board in spring 2017, not quite a year after his prostatectomy at the University of New Mexico Cancer Center. By the time he was in his mid-60s, Rod had been charting annual PSA readings; however, he now wishes he’d known about the significance of what such a collection of slightly increasing readings can mean. Upon his diagnosis, a relative urged him to go to PCSANM’s office, get to know people, and start becoming educated. He did.

Rod worked at Sandia National Labs for about 35 years in the public relations area. Rod continues to enjoy running events of various distances (maybe not marathons any longer), swimming (although he’s awful at it), and biking. There is also family of various generations and locations. A former college DJ and newspaper record review columnist, he’s got loads of music; he’d be happy to discuss with you.

Charles Rowland

Charles Rowland

Treasurer

Charles first became involved with PCSANM in January of 2011, just prior to undergoing a robotic radical prostatectomy. In the following months, it became evident that a metastasis had occurred prior to the surgery. The diagnosis had predicted low-grade cancer but the post-operative biopsy revealed a stage III cancer that was extremely aggressive. Within three months of surgery, however, he was able to resume cycling, a lifelong passion, and he continues to ride approximately 300 miles per month. He is now in the active surveillance protocol and is grateful that his PSA levels have remained so low that no further treatment has been necessary. Over the years, he has sharpened his focus within PCSANM to promote awareness in our broader society of the benefits of early diagnosis. 

 

Jan Marfyak

Jan Marfyak

Secretary

Following graduate school in Wisconsin, Jan joined Wisconsin state government, initially working with the state police, later as a Special Assistant to the State Health Officer, and finally as a Budget and Management Analyst and Director. In 1972, he moved to Washington DC, where he joined the US Department of Justice and later the US Department of Energy. He retired in 1995.

Jan was diagnosed with prostate cancer in 1992. After three years of surveillance, he elected seed implants and external beam radiation for treatment. Today his PSA remains less than detectable. In 2016, he was also diagnosed with bladder cancer. The cancer tumor was removed and he underwent chemotherapy. He is in remission.

Jan was instrumental in setting up a state prostate cancer coalition in Pennsylvania and was co-founder in establishing the National Organization of State Prostate Cancer Coalitions (NASPCC) which now has 38 member states. Jan joined the Prostate Cancer Support Association of New Mexico Board in 2007 when he moved to New Mexico.  

Lou Reimer

Lou Reimer

Board Member

Louis Reimer (Lou) has served on Prostate Cancer Support Association Board of Directors for the past eight years and was elected as Chairman in July, 2012, serving in that capacity until the election of the current Chairman, Steve Denning, in July, 2016. In addition, Lou has been, and continues to perform the duties of Programs Chairman.

Lou was diagnosed with prostate cancer in 2002 at age 63 while living in Southern California. His “Numbers” at diagnosis were: PSA =10.5, Gleason 8 and several nodules on the left side of the prostate.

The local USToo support group was instrumental in changing his approach from surgery to ADT and helped him get an appointment with an Oncologist specializing in treating prostate cancer. The Oncologist ordered a Prostascint scan that showed prostate cancer in the prostate, the surrounding tissue, the seminal vesicles, and abdomen. The Oncologist prescribed 19 months of aggressive ADT – a combination of Lupron, Casodex, and Proscar. This combination was very effective in forcing the PSA to a nadir of 0.004 during treatment. Afterwards the PSA rebounded to 0.03 and then declined to <0.01, where it has remained for many years.

He is grateful for the education and support from the knowledgeable USToo members in Southern California. When Lou moved to New Mexico he joined the local USToo chapter,  Prostate Cancer Support Association of New Mexico. He is trying to educate and support newly (and not so newly diagnosed) patients as a way to repay the debit he owes to the support personnel that got him on a good track.

Eli Maestas

Eli Maestas

Board Member

Eli was diagnosed with prostate cancer in 2012 and opted for radical prostatectomy followed by seven weeks of radiation. His PSA continued to rise so he underwent androgen deprivation therapy with Lupron. His PSA has been under control for four years. In 2014, he joined the Board of Directors to surround himself by those knowledgeable about prostate cancer.

Eli is a retired mechanical engineer and worked for 40 years in the nuclear energy industry. He has traveled extensively in Europe and around the world. In addition to traveling, he enjoys being involved in the restoration and preservation of vintage Corvettes. 

Dave Ball

Dave Ball

Board Member

David was first diagnosed with prostate cancer in December, 2007 and has been treated twice with radiation therapy. He is currently receiving intermittent hormone therapy. David’s goal is to make available to others diagnosed with prostate cancer the same outstanding assistance and information he received from PCSANM so they may have a great quality of life while managing their prostate cancer.

David retired in January, 2008 after 40 years working for the government and private industry as an Engineer and Project/Program Manager. David graduated from the University of New Mexico with a BS degree in Mechanical Engineering and an MS degree in Civil Engineering from New Mexico State University. David enjoys spending much of his time with his wife Louella, three daughters, and four grandchildren. In his spare time David plays golf and enjoys providing his services to PCSANM.

Phil York

Phil York

Board Member

After 17 years of monitoring his PSA, Phil had a biopsy with prostate cancer cells. Finding resources and the “Buddy List” at Prostate Cancer Association of New Mexico, he chose external beam radiation in 2017. Phil is volunteering as a member on the board as a way to pay back the valuable information and support the association provided to him.

Phil is a semi-retired Communications Technician from Public Service Co. of New Mexico and now maintains Automated Weather Observations Systems at small New Mexico airports.

Audrey Sniegowski

Audrey Sniegowski

Board Member

Audrey joined the board in 2019. She has been an oncology nurse for over 20 years. She received her master’s degree with a focus in oncology nursing in 1987 from the University of WI- Madison. Audrey currently works at the New Mexico Veteran’s Administration Medical Center in the urology department as a cancer center coordinator. She started a veteran centered prostate cancer support group that has partnered with PCSANM. She finds it rewarding teaching patients about their cancer and treatments. She enjoys advocating for cancer patients and coordinating their care. In her free time she enjoys reading, crafts, hiking, camping, and spending time with family and friends.

 

Advisory Board:

Michael Davis, MD

Advisory Board Member

Robert Leibowitz, MD

Advisory Board Member

Thomas Schroeder, MD

Advisory Board Member

Satyan Shah, MD

Advisory Board Member